Naltrexone

Naltrexone pills

Last published: October 07, 2026

What is naltrexone?

Naltrexone is a prescription drug. It belongs to a group of drugs known as opioid antagonists.

Opioid antagonists block the reward effects of heroin and other opioid drugs and reduce cravings.1

By blocking opioid receptors, naltrexone can also reduce the reward effects of alcohol and reduce alcohol cravings.2

Naltrexone is used in pharmacotherapy, where a legally prescribed drug is given to help treat a person’s alcohol or others drugs dependence.3

Naltrexone may be used:

  • as a treatment for people with alcohol dependence
  • as a treatment for people with opioid dependence such as heroin once they have withdrawn from opioids.4, 5

What does naltrexone look like?

Naltrexone is available in tablet form.6

Other names

Common naltrexone brand names:

ARX-Naltrexone®, Naltrexone GH®.

How is naltrexone used?

Naltrexone is taken as a tablet and usually taken daily. The length of the course will depend on each person’s needs and situation.6

Naltrexone can also be administered via an implant, an unregistered form of naltrexone treatment which is yet to be supported by high-quality evidence. It can be accessed in Australia under the TGA Special Access Scheme.

Naltrexone for alcohol or opioid dependence

To be eligible for naltrexone treatment, a person must:

  • not be currently using any opioids* or require opiate-based pain relief
  • have no existing liver conditions, such as acute hepatitis (liver function tests may be required before and during naltrexone treatment)
  • seek advice if you are pregnant or breastfeeding.4, 7

* If using naltrexone for opioid dependence a person typically needs to be free of opioids for 7–10 days before starting naltrexone treatment; otherwise they may experience instant withdrawal. Sometimes people are tested to confirm they are no longer using opioid drugs before beginning treatment. An example is the Naloxone Challenge Test (NCT), where naloxone is administered to understand a person’s current level of physical dependence on opioids.3

How effective is it?

Naltrexone may not work for everyone, so it’s important to consult a doctor or alcohol and other drug (AOD) counsellor to find the best approach.

Generally, naltrexone treatment is more likely to be effective if a person has good social support and they are highly motivated to change.8, 9

When treating alcohol dependence, naltrexone may work better at reducing heavy drinking and overall alcohol use than at helping people stay completely alcohol-free.10

Effects of naltrexone

The use of any drug can have risks. It’s important to be careful when taking any type of drug.

Naltrexone can affect everyone differently, based on:

  • size, weight and health
  • whether the person is used to taking it
  • whether other drugs are taken around the same time
  • the amount taken.

Onset and duration of effects

How fast a drug takes effect and how long it lasts can vary depending on how it's taken.

Naltrexone is usually taken daily as an oral tablet, but it can also be injected monthly in an extended-release form.6, 11

Side effects

Naltrexone has few side effects, and they are usually mild. Side effects may be reduced by taking naltrexone with food and often go away once your body gets used to the medication.12

Common side effects include:

  • nausea
  • headache
  • dizziness
  • drowsiness
  • stomach pain
  • reduced appetite
  • nervousness
  • restlessness
  • sweating.13, 14

Less common side effects include:

  • feeling energetic
  • thirst
  • diarrhoea, constipation
  • skin rashes
  • delayed ejaculation
  • irritability
  • chills.14

Overdose

Naltrexone lowers a person’s tolerance to opioids. This means there is a serious risk of overdose if a person uses an opioid during or after naltrexone treatment finishes.15

If opioids have been taken during or immediately after naltrexone treatment, call triple zero (000) and request an ambulance if you or someone else has any of the following symptoms (emergency services are there to help and can provide instructions over the phone):

Signs of opioid overdose can include:

  • unconscious or non-responsive
  • slow breathing, abnormal breathing, or not breathing at all
  • slow or no heartbeat and pulse
  • choking or gurgling sounds
  • skin colour changes, especially lips and fingernails
  • bluish-purple skin for people with lighter complexions
  • greyish or ashen skin for people with darker complexions
  • vomiting
  • cool or clammy (wet and sweaty) skin
  • small ‘pinpoint’ pupils.16, 17

Learn more on overdose and drug-related emergencies

Naloxone

Naloxone (also known as Nyxoid®/Narcan®) temporarily reverses the effects of opioid overdose. It’s available for free over the counter from most local pharmacies and can be administered by anyone, including family or friends and bystanders.18

If a person does not respond to the first dose after 3 minutes, give them a second dose. This can be repeated until the ambulance arrives.19, 20

Find naloxone near you

Mixing naltrexone with alcohol and other drugs

Mixing naltrexone with other drugs can have unpredictable effects and increase the risk of harm.

Mixing includes using more than one drug (including alcohol or medications) at the same time, or one after another. You should also consider what drugs you’ve taken in the last 24 hours.

  • Naltrexone and alcohol: if a person drinks alcohol while using naltrexone, they will still experience the impairment effects of alcohol. Their judgement, coordination and ability to do things like drive a car or operate machinery will still be affected.7
  • Naltrexone and opioids (codeine, heroin, oxycodone): naltrexone lowers a person’s tolerance to opioids, and makes an overdose more likely if opioids like heroin are used after missing a naltrexone dose or stopping treatment.

If you are taking naltrexone:  

  • Inform medical staff if you are likely to be given opioid painkillers (such as codeine or oxycodone) so they can care for you properly.
  • Always start with a small amount if you plan to use heroin, oxycodone, or other opioids, to prevent the risk of overdose and keep naloxone nearby.14, 21

Using more than one drug or type of drug at the same time is called polydrug use.17

Reducing harm

There are ways you can reduce the risk of harm when taking naltrexone:

  • Follow your doctors’ instructions on how and when to take naltrexone. Do not stop taking naltrexone or change the dose without talking to your doctor.
  • Naltrexone may affect your alertness and/or coordination.  Avoid driving or using machinery if you feel affected.
  • Do not use naltrexone if you have used opioids within 7-10 days.
  • Do not use naltrexone if you have liver disease or liver failure.
  • If you experience any side effects or discomfort, talk to your doctor to make sure that naltrexone is right for you.
  • Naltrexone has the potential to interact with several drugs and medications.  Talk with your doctor about the other drugs and medications you use.
  • Tell your doctor if you are pregnant or breastfeeding, or plan on becoming pregnant, while taking naltrexone.14

Coming down

Naltrexone is not known to cause comedown effects

Long-term effects

There is limited information on the long-term effects of naltrexone.

People taking naltrexone pharmacotherapy usually take it for about 3 to 6 months, with some people needing treatment for up to 12 months.6

Naltrexone and mental health

One of the main uses for naltrexone is the treatment of alcohol dependence. It’s also sometimes used for opioid dependence.6

The relationship between naltrexone, alcohol, and mental health is complex.

For example, some people may drink alcohol to cope with their mental health concerns. Although alcohol might feel like it relieves symptoms of anxiety or depression in the short term, it is more likely to lead to longer-term anxiety and depression.22, 23

However, pharmacotherapies for alcohol, such as naltrexone, can improve physical and mental health by reducing alcohol intake, withdrawal symptoms, and cravings.4, 24, 25

Pharmacotherapy provides greater life stability, supporting improved wellbeing, relationships, and social functioning.4, 26

Tolerance

There is no evidence that naltrexone causes tolerance.

Dependence

There is no evidence of physical dependence for patients talking naltrexone pharmacotherapy.6

A person who enters a naltrexone pharmacotherapy program for alcohol or opioid dependence can rely on naltrexone to reduce the desirable effects of drugs. The program can help them stop or reduce their use of alcohol or opioids and, as a result, reduces their risk of related harms.27

Withdrawal

Withdrawal refers to the symptoms that can occur when someone who is dependent on a drug, or who has been using it regularly over time, stops or reduces their use.28

Withdrawal can include physical symptoms (such as headaches, or nausea) and psychological symptoms (such as anxiety, or depressed mood).28

Symptoms - including how strong they are and how long they last - will vary depending on the type of drug and a person’s history of use.28

There are no known naltrexone withdrawal symptoms, however if you experience symptoms after stopping use, or have concerns, contact your doctor or the help and support services listed below for advice and support.6

Social and emotional support should continue after pharmacotherapy ends to prevent a return to previous levels of alcohol use.6

Precipitated withdrawal

If a person is currently dependent on opioids, or regularly takes opioid medications, they can experience sudden withdrawal symptoms when they are given naltrexone.29

While these symptoms can be very unpleasant, they should go away as the naltrexone wears off.

Reduced tolerance and overdose risk

Naltrexone can be used in treatment for opioid dependence.4

After withdrawing from opioids, your body is no longer used to it and your tolerance drops. This means if you use the same amount as before, it can be too much for your body and cause an overdose. Always start with a lower dose after a break from opioids.30

Pregnancy and breastfeeding

There haven’t been many large studies on naltrexone use and pregnancy, meaning there’s not enough evidence to know the safety of naltrexone during pregnancy.31

Naltrexone can pass to the unborn baby via the placenta. Some studies in animals have found an increased risk of harm to the developing baby. However, no long-term effects on babies have been observed in people who have taken naltrexone during pregnancy.31, 32

Naltrexone can also pass to the baby through breastmilk. But this doesn’t appear to cause any harmful effects for the baby or pregnant person.32

One potential benefit of naltrexone compared with other opioid pharmacotherapies is a lower risk of neonatal opioid withdrawal syndrome in the baby. But, more studies are needed to prove this.11, 33

The potential benefits and risks of naltrexone should be considered for each person individually. If you’re pregnant or trying to become pregnant, talk to your doctor about using naltrexone for alcohol or opioid dependence treatment.31

Getting Help

If your use of alcohol or other drugs is affecting your health, family, relationships, work, school, financial or other life situations, or you’re concerned about someone, there is help and support.

Path2Help

Not sure what you are looking for?
Try our intuitive Path2Help tool and be matched with support information and services tailored to you.

Find out more
Image of a woman walking through a maze

Naltrexone is a Schedule 4 medication. It is a medicine that a healthcare provider, such as your doctor, can prescribe to you.  You can take your prescription to your pharmacist (chemist), who can supply this medication to you.

Using naltrexone without a prescription from a doctor, or selling or giving it to someone else, is illegal.  There are also laws against forging or altering a prescription or making false representation to obtain naltrexone or a prescription for it.34

See also, drugs and the law.

  • Naltrexone has been the most prescribed alcohol cessation medication in Australia since 2014.
  • Over 21,175 people in Australia used naltrexone in 2021-2022.
  • Men were more likely to be prescribed alcohol cessation medication than women in 2021-22 (57.1% vs 42.9%).
  • Since 2012, people ages 40-49 have been accessing alcohol cessation medication at higher rates than the rest of the Australian population.
  • People living in inner regional areas of Australia were more likely to be prescribed alcohol cessation medication than those living in major cities or outer regional or remote areas in 2021-22.35
  1. Korsmeyer P, Kranzler HR. Antagonists of Alcohol and Drugs [e-book]. 3rd ed. Vol.1 Detroit, MI: Macmillan Reference USA; 2009 [cited 08.04.2025].
  2. Miranda Jr R, Treloar Padovano H, JC G, SE W, Blanchard A. Real-Time Assessment of Alcohol Craving and Naltrexone Treatment Responsiveness in a Randomized Clinical Trial. Addictive Behaviours [Internet]. 2018. [cited 06.12.2024];1(83):72–8.
  3. Kranzler HR, Ciraulo DA. Clinical manual of addiction psychopharmacology [e-book]. 1st ed. Washington, DC: American Psychiatric Pub.; 2005 [cited 2024 Dec 19].
  4. Gowing L, Ali R, Dunlop A, Farrell M et al. National Guidelines for Medication-Assisted Treatment of Opioid Dependence. Australian Government Department of Health; 2014. [cited 2026 Sep 15]
  5. McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, et al. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA [Internet]. 2023. [cited 06.12.2024];330(17):1653–65.
  6. Morley K, Rombouts S, Jamshidi N, Haber P. Chapter 10: Pharmacotherapies. Guidelines For The Treatment Of Alcohol Problems, [e-book]. 4th ed. Sydney: Specialty of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney, 2021.
  7. Haber PS, Riordan BC. Guidelines for the Treatment of Alcohol Problems. [Internet]. 2021. [cited 23.12.2025]:408.
  8. Tucker TK, Ritter AJ. Naltrexone in the treatment of heroin dependence: a literature review. Drug and Alcohol Review [Internet]. 2000.19(1):73–82.
  9. Lobmaier P, Kornor H, Kunoe N, Bjørndal A. Sustained‐Release Naltrexone For Opioid Dependence. Cochrane Database of Systematic Reviews [Internet]. 2008. [cited 06.12.2024]:44.
  10. Crowley P. Long-term drug treatment of patients with alcohol dependence. Australian Prescriber [Internet]. 2015. [cited 9.12.2024];38(2):41.
  11. Mantri S, Cheng A-C, Saia K, Shrestha H, Amgott R, Bressler J, et al. Neurobehavioral outcomes of infants exposed to buprenorphine-naloxone compared with naltrexone during pregnancy. Early Human Development [Internet]. 2024. [cited 2026 Sep 15];194
  12. Fairbanks J, Umbreit A, Kolla BP, Karpyak VM, Schneekloth TD, Loukianova LL, et al. Evidence-Based Pharmacotherapies for Alcohol Use Disorder. Mayo Clinic Proceedings [Internet]. 2020.95(9):1964–77.
  13. Bolton M, Hodkinson A, Boda S, Mould A, Panagioti M, Rhodes S, et al. Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis. BMC Medicine [Internet]. 2019. [cited [22.04.2024];17(1)
  14. Ltd APP. Arx-Naltrexone (Naltrexone Hydrochloride) Tablets Australian Approved Product Information. Australian Product Information [Internet]. 2024. [cited 9.12.2024]:15.
  15. Substance Abuse and Mental Health Services Administration. Naltrexone. 2020. [cited 06.10.2021]
  16. Schuckit MA. Drug and alcohol abuse : a clinical guide to diagnosis and treatment [e-book]. 6th ed.: Springer; 2006 [cited 2025 Feb 13].
  17. Darke S, Lappin J, Farrell M. The clinician's guide to illicit drugs and health [e-book]. Silverback Publishing; 2019 [cited 2026 May 15].
  18. Australian Government Department of Health and Aged Care. About the Take Home Naloxone program. 2024. [cited 2026 Sep 30]
  19. Nyxoid. Australian Product Information - Nyxoid® (Naloxone Hydrochloride Dihydrate) Nasal Spray). 2022. [cited 2026 Sep 30]
  20. Harm Reduction Victoria. 5 Steps To Life. Reverse Opioid Overdose. [cited 2025 Jul 24]
  21. Singh D, Saadabadai A. Naltrexone [e-book]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 06.12.2024].
  22. Jacob L, Smith L, Armstrong NC, Yakkundi A, Barnett Y, Butler L, et al. Alcohol use and mental health during COVID-19 lockdown: A cross-sectional study in a sample of UK adults. Drug and alcohol dependence [Internet]. 2021. [cited 2026 Oct 1];219:108488.
  23. Puddephatt J-A, Jones A, Gage SH, Fear NT, Field M, McManus S, et al. Associations of alcohol use, mental health and socioeconomic status in England: Findings from a representative population survey. Drug and alcohol dependence [Internet]. 2021. [cited 2026 Oct 1];219
  24. SA Health. Medication assisted treatment for alcohol dependence. Government of South Australia; 2025. [cited 2026 Sep 16]
  25. Deyo C, Membrey D, Conigrave K, Corbet D, Garry S, Grover C, et al. Naltrexone: A safe and effective standard of care in treating alcohol use disorder. Australian Journal of General Practice [Internet]. 2026. [cited 2026 Oct 2];55:49–52.
  26. Lowry N, Najia C, Kelleher M, Mitcheson L, Marsden J. Patient experience of opioid use disorder treatment medications: a systematic review of contemporary qualitative research. BMJ Open [Internet]. 2024. [cited 2026 Sep 15];14(12):e088617.
  27. Harm Reduction Victoria. PAMS Pharmacotherapy Advocacy Mediation Support. n.d. [cited 2026 Sep 15]
  28. NSW Ministry of Health. Management of Withdrawal from Alcohol and Other Drugs: Clinical Guidance. 2022. [cited 2026 Sep 11]
  29. Dunn KE, Bird HE, Bergeria CL, Ware OD, Strain EC, Huhn AS. Operational definition of precipitated opioid withdrawal. Frontiers in Psychiatry [Internet]. 2023. [cited 2026 Oct 1];14
  30. Nutt DJ. Drugs without the hot air : making sense of legal and illegal drugs [e-book]. Revised & updated second edition. [US & CA territories version] ed. Cambridge: UIT Cambridge Ltd.; 2020 [cited 2026 Sep 23].
  31. Burns L, Hutchinson D. Chapter 14: Pregnant and Breastfeeding Women. Guidelines For The Treatment Of Alcohol Problems, [e-book]. 4th ed. Sydney: Specialty of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney, 2021 [cited 2026 Sep 15].
  32. Towers CV, Katz E, Weitz B, Visconti K. Use of naltrexone in treating opioid use disorder in pregnancy. American journal of obstetrics and gynecology [Internet]. 2020.222(1):83.e1–.e8.
  33. Atluru S, Bruehlman AK, Vaughn P, Schauberger CW, Smid MC. Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review. Obstetrics and gynecology [Internet]. 2024. [cited 2026 Sep 15];143(3):403–10.
  34. Drugs, Poisons and Controlled Substances Act 1981 (Vic). [Internet]. 1981. [cited 2024 Dec 09]
  35. Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia. [Internet]. Canberra (AU): AIHW; 2024. Data tables: Alcohol, tobacco and other drugs in Australia – Pharmaceutical Benefits Scheme analysis. [cited 20.05.2024]

Effects

reverse opioid overdose